Jefferies analyst Faisal Khurshid upgraded Abivax (NASDAQ: ABVX) from Hold to Buy with a price target of $158.00 (from $108.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE